Molecular immunology and immunotherapy for chronic sinusitis

Current Allergy and Asthma Reports

Volumn 3, Issue 6, 2003, Pages 505-512

  Nguyen, Lily H P ^a   Fakhri, Samer ^a   Frankiel, Saul ^a   Hamid, Qutayba A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD8 ANTIGEN; CHEMOKINE; CORTICOSTEROID; CYTOKINE RECEPTOR; FLUTICASONE PROPIONATE; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR BETA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MOMETASONE FUROATE; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; CYTOKINE;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; B LYMPHOCYTE; CHRONIC SINUSITIS; CLINICAL FEATURE; EOSINOPHIL; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; NOSE MUCOSA; REVIEW; T LYMPHOCYTE; TREATMENT FAILURE; CHRONIC DISEASE; RESPIRATORY TRACT INFECTION; SINUSITIS;

CHEMOKINES; CHRONIC DISEASE; CYTOKINES; GLUCOCORTICOIDS; HUMANS; IMMUNOTHERAPY; NASAL MUCOSA; RECEPTORS, GLUCOCORTICOID; RESPIRATORY TRACT INFECTIONS; SINUSITIS;

EID: 0642377584     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-003-0062-1     Document Type: Review

References (49)

1. Kaliner MA, Osguthorpe JD, Fireman P, et al.: Sinusitis: bench to bedside. Current findings, future directions. J Allergy Clin Immunol 1997, 99: S829-S848.
2. Kaliner MA, Osguthorpe JD, Fireman P, et al.: Sinusitis: bench to bedside. Current findings, future directions. Otolaryngology Head Neck Surg 1997, 116(Suppl): S1-S20.
3. Bolger WE, Butzin CA, Parsons DS: Paranasal sinus bony anatomic variations and mucosal abnormalities: CT analysis for endoscopic sinus surgery. Laryngoscope 1991, 101: 56-64.
4. Danese M, Duvoisin B, Agrifoglio A, et al.: Influence of nasosinusal anatomic variants on recurrent, persistent or chronic sinusitis: x-ray computed tomographic evaluation in 112 patients. J Radiol 1997, 78: 651-657.
5. Settipane GA: Epidemiology of nasal polyps. Allergy Asthma Proc 1996, 17: 231-236.
6. Hamilos DL, Leung DYM, Wood R, et al.: Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995, 96: 537-544.
7. Hamilos DL, Leung DY, Wood R, et al.: Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol 1993, 92: 39-48.
8. Wright ED, Hamid Q, Frenkiel S: Immune responses in the chronic inflammatory process within the paranasal sinus mucosa. In Cilia, Mucus, and Mucociliary Interactions. Edited by Baum G, Priel Z, Roth Y, et al. New York: Marcel Dekker; 1998:525-541.
9. Al-Chamdi K, Ghaffar O, Small P, et al.: IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and the effect of topical corticosteroid treatment. J Otolaryngol 1997, 26: 160-166.
10. Lopez AF, Sanderson CJ, Gamble JR, et al.: Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988, 167: 219-224.
11. Simon Hu, Yousefi S, Schranz C, et al.: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997, 158: 3902-3908.
12. Migita M, Yamaguchi N, Mita S, et al.: Characterization of the human IL-5 receptors on eosinophils. Cell Immunol 1991, 133: 484-497.
13. Wright ED, Frenkiel S, Al-Ghamdi K, et al.: Interleukin-4, interleukin-5, and granulocyte-macrophage colony-stimulating factor receptor expression in chronic sinusitis and response to topical steroids. Otolaryngol Head Neck Surg 1998, 118: 490-495.
14. Szabo SJ, Jacobson NG, Dighe AS, et al.: Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 1995, 2: 665-675.
15. Hamilos DL, Leung DY, Wood R, et al.: Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Resp Cell Mol Biol 1996, 15: 443-450.
16. Christodoulopoulos P, Cameron L, Durham S, et al.: Molecular pathology of allergic disease II: Upper airway disease. J Allergy Clin Immunol 2000, 105: 211-223.
17. Christodoulopoulos P, Wright ED, Frenkiel S, et al.: Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: effect of topical corticosteroids. J Allergy Clin Immunol 1999, 103: 1036-1044.
18. Emmanuel IA, Shah SB: Chronic rhinosinusitis: allergy and sinus computed tomography relationships. Otolaryngol Head Neck Surg 2000, 6: 687-691.
19. Kamil A, Ghaffar O, Lavigne F, et al.: Comparison of inflammatory cell profile and TH2 cytokine expression in the ethmoid sinus, maxillary sinus, maxillary sinus, and turbinate of atopic subjects with chronic sinusitis. Otolaryngol Head Neck Surg 1998, 118: 804-809.
20. Wright ED, Christodoulopoulos P, Frenkiel S, et al.: Expression of IL-12 (p40) and IL-12 (b2) receptors in allergic rhinitis and chrinic sinusitis. Clin Exp Allergy 1999, 29: 1320-1325.
21. Sobol SE, Christodoulopoulos P, Manoukian JJ, et al.: Cytokine profile in chronic sinusitis in patients with cystic fibrosis. Arch Otolaryngol Head Neck Surg 2002, 128: 1295-1298.
22. Demoly P, Crampette L, Mondain M, et al.: Myeloperoxidase and interleukin-8 levels in chronic sinusitis. Clin Exp Allergy 1997, 27: 672-675.
23. Feger T, Rupp N, Kuhn F, et al.: Local and systemic eosinophil activation. Ann Allergy Asthma Immunol 1997, 79: 221-225.
24. Manning SC, Holman M: Further evidence for allergic fungal sinusitis. Laryngoscope 1998, 108: 1485-1496.
25. Lavigne F, Cameron L, Renzi P, et al.: Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope 2002, 112: 858-864.
26. Kondo H, Nachtigal D, Frenkiel S, et al.: Effect of steroids on nasal inflammatory cells and cytokine profile. Laryngoscope 1999, 109: 91-97.
27. Cameron LA, Durham SR, Jacobson MR, et al.: Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids. J Allergy Clin Immunol 1998, 101: 330-336.
28. Masuyama K, Jacobson MR, Rak S, et al.: Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994, 82: 192-199.
29. Pawankar R, Okuda M, Yssel H, et al.: Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997, 99: 1492-1499.
30. Rousset F, Robert J, Andary M, et al.: Shifts in interleukin-4 and interferon-α production by T-cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol 1991, 87: 58-69.
31. Rak S, Jacobson MR, Sudderick RM, et al.: Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994, 24: 930-939.
32. Minshall E, Ghaffar O, Cameron L, et al.: Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Ololaryngol Head Neck Surg 1998, 118: 648-654.
33. Bascom R, Wachs M, Naclerio RM, et al.: Basophil influx occurs after nasal allergen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988, 81: 580-589.
34. Hamid Q. Wenzel SE, Hauk PJ, et al.: Increased glucocorticoid receptorβ in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 1999, 159: 1600-1604.
35. Hamilos DL, Leung DYM, Muro S, et al.: GRβ expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 2001, 108: 59-68.
36. Leung DYM, Hamid Q, Vottero A, et al.: Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med 1997, 186: 1567-1574.
37. Tulic MK, Manoukian JJ, Eidelman DH, et al.: T-cell proliferation induced by local application of LPS in the nasal mucosa of nonatopic children. J Allergy Clin Immunol 2002, 110, 771-776
38. Bunikowski R, Mielke M, Skarabis H, et al.: Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol 1999, 103: 119-124.
39. Leung DYM, Gately M, Trumble A, et al.: Bacterial superantigens induce T-cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen (CLA). J Exp Med 1995, 181: 747-753.
40. Hamid Q, Boguniewicz M, Leung DYM: Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 1994, 94: 870-876.
41. Durham SR, Ying S, Varney VA, et al.: Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 1996, 97: 1356-1365.
42. Hamid QA, Schotman E, Jacobson MR, et al.: Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 1997, 99: 254-260.
43. SM, Lavelle B, Kemeney DM, et al.: A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses. J Allergy Clin Immunol 1990, 86: 521-531.
44. Ohashi Y, Nakai Y, Okamoto H et al.: Significant correlation between symptom score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis. Ann Otol Rhinol Laryngol 1997, 106: 483-489.
45. Gajewski TF, Fitch FW: Anti-proliferative effect of IFN-gamma in immune regulation. I: IFN-gamma inhibits the proliferation of TH2 but not TH1 murine helper T lymphocyte clones. J Immunol 1988, 140: 4245-4252.
46. Mayer M, Doenicke A, Nebauer AE, et al.: Pharmacodynamics and clinical adverse effects of mivacurium: the effect of oral premedication with H1/H2 antagonists. Anaesthesist 1993, 42: 592-596.
47. Del Prete G, Maggi E, Parronchi P, et al.: IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988, 140: 4193-4198
48. Kuna P, Alam R, Kuzminska B, et al.: The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind, placebo-controlled, randomized study. J Allergy Clin Immunol 1989, 83: 816-824.
49. Durham SR, Walker SM, Varga EM, et al.: Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999, 341: 468-475.